Press releases and statements

Life-changing SMA drug Spinraza set to be available for NHS use in England

Spinraza – the first treatment for the rare condition spinal muscular atrophy (SMA) – is clinically proven to potentially extend life and improve mobility The drug is set to be made available on the NHS for children and adults with SMA Types 1, 2 and...

Read more
Keep in touch